Aveo Pharmaceuticals Inc
F:VPA1
Fundamental Analysis

Revenue & Expenses Breakdown
Aveo Pharmaceuticals Inc
Balance Sheet Decomposition
Aveo Pharmaceuticals Inc
Current Assets | 100.7m |
Cash & Short-Term Investments | 77.4m |
Receivables | 19.8m |
Other Current Assets | 3.6m |
Non-Current Assets | 502k |
PP&E | 257k |
Other Non-Current Assets | 245k |
Free Cash Flow Analysis
Aveo Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Aveo Pharmaceuticals Inc
Revenue
|
94.3m
USD
|
Cost of Revenue
|
-11.5m
USD
|
Gross Profit
|
82.8m
USD
|
Operating Expenses
|
-107.3m
USD
|
Operating Income
|
-24.5m
USD
|
Other Expenses
|
-4.5m
USD
|
Net Income
|
-29m
USD
|
VPA1 Profitability Score
Profitability Due Diligence
Aveo Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Aveo Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
VPA1 Solvency Score
Solvency Due Diligence
Aveo Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Aveo Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VPA1 Price Targets Summary
Aveo Pharmaceuticals Inc
Dividends
Current shareholder yield for VPA1 is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?